CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Echo Therapeutics

Echo Therapeutics is developing its Symphony CGM System as a non-invasive, wireless, continuous glucose monitoring system. A significant consumer (non-regulated) opportunity also exists for Symphony to be used in the fitness, weight loss and personal lifestyle space. Echo also developed its needle-free skin preparation device as a platform technology that allowed for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.

Career Directions NW

Career Directions NW is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

First Service Administrators

First Service Administrators is a Winter Haven, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centro Latino de Chelsea

Centro Latino de Chelsea is a Chelsea, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dental365

Contact one of our Dental365 offices near you for the best dental care in NY, Connecticut, NJ, Massachusetts & Rhode Island.